Showing 5471-5480 of 10417 results for "".
- Vitiligo Linked to Elevated Risk of Herpes Zoster: Cohort Studyhttps://practicaldermatology.com/news/vitiligo-linked-to-elevated-risk-of-herpes-zoster-study-finds/2485328/A new cohort study from Taiwan indicated vitiligo is independently associated with a heightened risk of herpes zoster (HZ), with systemic immunosuppressive therapies compounding the risk further. Using data from Taiwan's Longit
- Analysis: CHL-Fe-based PDT Shows Activity Against Drug-Resistant C. acneshttps://practicaldermatology.com/news/chl-febased-photodynamic-therapy-shows-potent-activity-against-drug-resistant-c-acnes/2485327/Photodynamic therapy (PDT) using sodium iron chlorophyllin (CHL-Fe) and red light achieved consistent bactericidal effects against drug-resistant Cutibacterium acnes (C. acnes) strains in vitro, according to new study finding
- Study: Photodynamic Therapy Usage Shifts With Season, Geographyhttps://practicaldermatology.com/news/study-photodynamic-therapy-usage-shifts-with-season-geography/2485308/Seasonal and geographic variation influences the use of photodynamic therapy (PDT) for actinic keratoses (AKs), according to a large cross-sectional study. Reasearchers analyzed over 79 million procedural claims from 2015 to 202
- Analysis: Ustekinumab, IL-23 Inhibitors Show Higher Drug Survival in Psoriasishttps://practicaldermatology.com/news/analysis-ustekinumab-il-23-inhibitors-show-higher-drug-survival-in-psoriasis/2485295/A new Danish cohort study using data from the DERMBIO registry suggests ustekinumab was linked with the best 5-year survival of comparators in bionaive patients with psoriasis. The analysis included a total of 7,193 treatment
- MEK Inhibition Shows Promise in Aggressive EB-Linked Skin Cancershttps://practicaldermatology.com/news/mek-inhibition-shows-promise-in-aggressive-eb-linked-skin-cancers/2485197/A transcriptome-driven drug repurposing strategy has identified selumetinib as a potential therapeutic candidate for aggressive squamous cell carcinomas (SCCs) arising in recessive dystrophic epidermolysis bullosa (RDEB). Resea
- Analysis Suggests Possible 'Oral–Gut–Skin Axis' in HShttps://practicaldermatology.com/news/analysis-suggests-possible-oralgutskin-axis-in-hs/2485169/New microbiome research comparing acne and hidradenitis suppurativa (HS) across multiple anatomical sites shows unique microbial signatures that may aid researchers in explaining the chronic HS phenotype. The study authors ana
- FDA: Most PFAS in Cosmetics Lack Adequate Safety Datahttps://practicaldermatology.com/news/fda-most-pfas-in-cosmetics-lack-adequate-safety-data/2485144/The U.S. Food and Drug Administration (FDA) announced that it has released its first congressionally mandated report under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), assessing the use and safety of perfluoroalkyl and polyfluoroalkyl substances (PF
- Systematic Review Suggests Anti-Inflammatory Effects of Astragalus membranaceushttps://practicaldermatology.com/news/systematic-review-shows-anti-inflammatory-effects-of-astragalus-membranaceus/2485129/A new systematic review suggests the traditional botanical Astragalus membranaceus may have clinically relevant anti-aging benefits. "The demand for cosmetic strategies to mitigate [skin ag
- Study: Gut Permeability Biomarker Linked with AD Symptom Reliefhttps://practicaldermatology.com/news/study-gut-permeability-biomarker-linked-with-ad-symptom-relief/2485110/New research suggests serum D-lactate levels may predict clinical response to washed microbiota transplantation (WMT), showing the role of intestinal barrier dysfunction in atopic dermatitis (AD). Researchers for the prospective
- Study Links BMI and IBD Causally to Hidradenitis Suppurativahttps://practicaldermatology.com/news/mendelian-randomization-study-links-bmi-and-ibd-causally-to-hidradenitis-suppurativa/2485068/A new mendelian randomization (MR) analysis provides genetic evidence supporting a causal role for elevated body mass index (BMI) and inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS). Study researchers used gen